ITM Power's High-Volatility Trap: How MSCI Inclusion and Sector Contagion Triggered a 27% Weekly Rout

ITM Power stock crashes 26.75% after MSCI index inclusion and peer downgrades. Despite £86.5M government backing, market awaits Chronos program commercial proof. High volatility.

The scale of the selloff is hard to ignore. ITM Power shares crashed 14.45% on Friday alone, closing at €1.68, and over the past seven trading sessions the cumulative loss stands at 26.75%. For a stock that still shows year-to-date gains of 131.01% and a 12-month advance of 130.70%, the reversal from last week’s peak of €2.58 has been brutal. But this is no ordinary pullback — it is a textbook example of how high-volatility assets, with an annualised fluctuation range north of 100%, can unwind in days what took months to build.

The immediate trigger was the classic “sell the fact” phenomenon following ITM Power’s inclusion in the MSCI UK Small Cap Index at the end of May. Since the index change was announced in mid-May, hedge funds and arbitrageurs had piled in, betting that passive ETF flows would lift the stock. Once the rebalancing was completed, those speculative positions were rapidly liquidated. The supply of shares overwhelmed demand, sending the price plunging back below €1.70 in a matter of days.

Compounding the index-driven exodus was a fresh wave of sector scepticism. On 4 and 5 June, analysts at Panmure Liberum downgraded peer Ceres Power from “Buy” to “Sell,” citing a growing gap between technological promise and commercial execution. The reversal rippled across the hydrogen space. Ballard Power Systems lost 19% on the same Friday, Plug Power shed about 12%, and Clean Power Hydrogen’s announcement of an irreparably damaged pilot electrolyser further dented confidence in the technology’s scalability. ITM Power, heavily dependent on speculative froth, bore the brunt of the contagion.

None of this negates the tangible government backing the company has secured. Great British Energy invested £40 million, taking a 10.4% stake, while the UK energy ministry granted £46.5 million specifically for a new 1-gigawatt automated production line in Sheffield. The combined £86.5 million injection is now under review by the Competition and Markets Authority — a regulatory step that will determine whether the full amount reaches the Sheffield factory. The state’s financial seal of approval is a powerful endorsement, but the market is demanding proof of commercial execution before it prices that support in fully.

That proof revolves around the Chronos programme, the single most consequential operational catalyst on the horizon. The new electrolyser unit is designed to deliver 2.5 megawatts, run 10% more energy-efficiently, cut investment costs by 40%, and require half the physical footprint of current models. If the final investment decision is positive, ITM Power will build a fully automated 1-gigawatt line targeting commercial production in 2028. The decision is a make-or-break test not just of technological ambition but of industrial-scale manufacturing — a threshold where many hydrogen peers have stumbled.

Several other projects also hang in the balance. The UK’s Hydrogen Allocation Round 2 (HAR2) offers up to 875 megawatts of capacity, with 27 projects shortlisted. ITM Power is already named preferred supplier for two of them, but both depend on final investment decisions by developers. Uniper’s Killingholme project, a 120-megawatt facility, is another key lever: the FEED contract was signed in June 2025, planning permission granted in March 2026, and a final investment decision expected this year. ITM is ready to supply six Poseidon modules of 20 megawatts each, with commissioning slated for 2029 and a possible expansion beyond 200 megawatts. Separately, a strategic partnership with Protium Green Solutions will target industrial green hydrogen plants in Britain, starting with the 15-megawatt Cromarty Hydrogen project in the Scottish Highlands. A final investment decision there is due in December 2026.

Operationally, the company has been moving in the right direction. Revenue guidance for fiscal 2026 was raised to between £40 million and £43 million, signalling improved visibility on orders. The order book stands at £152 million, with 71% of that backlog deemed profitable. The first-half EBITDA loss narrowed to £11.9 million from £16.8 million a year earlier, and management expects the full-year loss to land between £27 million and £29 million. Net cash of roughly £200 million provides a runway of more than three years based on existing orders. That gives time, but it does not replace the need for contracts with visible margins.

Jefferies, which rates the stock a “Buy” with a price target raised from 115 to 200 pence, projects current-year revenue of £41 million, rising to £56 million and £71 million over the following two years. The analyst expects EBITDA breakeven in 2028 — the point at which government grants, partnerships, and order options must translate into real earnings. In a negative scenario, Jefferies sees downside of 52%; in a positive scenario, upside of 37%. That wide asymmetry reflects how stretched the valuation has become after the rally.

The divergence among the Street’s calls is striking. Goldman Sachs sticks with “Sell,” lifting its target only slightly from 55 to 63 pence — still well below the current share price. Berenberg also rates it a “Buy” but raised its target more modestly from 100 to 110 pence. UBS remains “Neutral” with a 60-pence target. The debate is not about technology; it is about speed of commercialisation, valuation, and cashflow.

Retail investors, however, are undeterred. On one UK trading platform, 63% of ITM Power orders during a recent morning session were buys. The drop is being treated as a buying opportunity, not a signal to exit. That retail enthusiasm is a double-edged sword — it provides short-term demand but adds to the stock’s volatility.

Technically, the first support level is the 50-day moving average at €1.56. The relative strength index of 42.3 is approaching oversold territory, and a break below the 200-day moving average of €0.99 would threaten the year-to-date gain of 131%. Until the next set of results in September, the pace will be set by the Chronos decision, HAR2 developments, and Killingholme’s final investment call. The state’s money and the partnerships provide a foundation, but the market wants to see those catalysts harden into binding orders with visible margins.